Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

<p>Understanding of the biology and clinical behavior of ductal carcinoma in situ (DCIS) is currently inadequate. The aim of this comprehensive review was to identify important molecular biological markers associated with DCIS and candidate markers associated with increased risk of ipsilateral...

Full description

Bibliographic Details
Main Author:	Sara A. Lari, Henry M. Kuerer
Format:	Article
Language:	English
Published:	Ivyspring International Publisher 2011-01-01
Series:	Journal of Cancer
Online Access:	http://www.jcancer.org/v02p0232.htm

Similar Items

Biological Markers Predictive of Invasive Recurrence in DCIS
by: Sharon Nofech-Mozes, et al.
Published: (2008-01-01)

Microcalcification crystallography as a potential marker of DCIS recurrence
by: Sarah B. Gosling, et al.
Published: (2023-06-01)

A low risk of recurrence after breast-conserving surgery for DCIS: A single-institution experience
by: Sara van Bekkum, et al.
Published: (2023-01-01)

Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI
by: Ga Eun Park, et al.
Published: (2022-03-01)

Expression score (Escore) for the prediction of likelihood of recurrence of DCIS
by: Badve, SS, et al.
Published: (2019)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01)

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast
by: Judith-Anne W. Chapman, et al.
Published: (2008-01-01)

Ductal carcinoma in situ (DCIS) in breast fibroadenoma
by: Manar El-Essawy, et al.
Published: (2020-05-01)

Is palpable DCIS more aggressive than screen-detected DCIS?
by: Nina Balac, et al.
Published: (2023-01-01)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
by: Fredrik Wärnberg, et al.
Published: (2021-12-01)

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
by: Jasmine Timbres, et al.
Published: (2023-09-01)

P007 Tamoxifen reduced breast cancer recurrence in women with DCIS who underwent mastectomy
by: N. Saesim, et al.
Published: (2023-03-01)

A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay
by: Rachel Y. Lei, MA, et al.
Published: (2021-03-01)

Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
by: Lindsay A Williams, et al.
Published: (2019-01-01)

Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis
by: Drissa Ouattara, et al.
Published: (2023-03-01)

The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
by: Keris Poelhekken, et al.
Published: (2023-10-01)

The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
by: Sena Alaeikhanehshir, et al.
Published: (2020-04-01)

DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast
by: Huanyu Zhao, et al.
Published: (2022-10-01)

Unusual mammography findings of patients with ductal carcinoma in situ (DCIS) of the breast.
by: F Ismail, et al.
Published: (2008-03-01)

Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases
by: Stefanie Corradini, et al.
Published: (2018-02-01)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
by: Li-Na Yu, et al.
Published: (2019-12-01)

Male Breast Cancer Review. A Rare Case of Pure DCIS: Imaging Protocol, Radiomics and Management
by: Daniele Ugo Tari, et al.
Published: (2021-11-01)

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
by: Danalyn Byng, et al.
Published: (2021-08-01)

Personalizing the Treatment of Women with Ductal Carcinoma In Situ (DCIS) Using the DCIS Score: A Qualitative Study on Score Use
by: Mary Ann O’Brien, et al.
Published: (2024-02-01)

Association of the 12-Gene Breast DCIS Score® Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols
by: Charles E. Leonard, et al.
Published: (2021-06-01)

Countercurrents: DCIS or Cancer? Why All the Confusion?
by: Steven A. Narod, et al.
Published: (2022-07-01)

Heterogeneity between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma (DCIS) of the Breast
by: Naomi A. Miller, et al.
Published: (2010-01-01)

Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion
by: Mary-Kate Hayward, et al.
Published: (2022-09-01)

Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.
by: Virginia Espina, et al.
Published: (2010-01-01)

Tools to Guide Radiation Oncologists in the Management of DCIS
by: Maria Cristina Leonardi, et al.
Published: (2024-04-01)

Epithelioid myofibroblastoma with concurrent presentation of LCIS and DCIS
by: Amer Safdari, MS, et al.
Published: (2023-06-01)

Educational Case: Ductal Carcinoma In Situ (DCIS)
by: Miglena K. Komforti DO, et al.
Published: (2019-11-01)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
by: Sunil S. Badve, et al.
Published: (2022-08-01)

Challenging paradigms: Long non-coding RNAs in breast ductal carcinoma in situ (DCIS)
by: Mary Ann Kosir, et al.
Published: (2013-04-01)

Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast
by: David E. Axelrod, et al.
Published: (2010-09-01)

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
by: Ismet Sarikaya, et al.
Published: (2020-01-01)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
by: Anna Niwińska, et al.
Published: (2021-12-01)

Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
by: Ezra Hahn, et al.
Published: (2023-06-01)

A longitudinal cohort study to identify risk factors for the development of invasive cancer in unresected DCIS
by: Maxwell, AJ, et al.
Published: (2018)

Eligibility, uptake and response to germline genetic testing in women with DCIS
by: Lauren Turza, et al.
Published: (2022-08-01)